Judith Silverstein Currier MD
HIV/AIDS Medicine
Professor of Medicine, UCLA-David Geffen School of Medicine
Join to view full profile
11075 Santa Monica Blvd100Los Angeles, CA 90025
Phone+1 310-825-6689
Fax+1 310-825-6689
Dr. Currier is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Judith Currier is Professor of Medicine and Chief of the Division of Infectious Diseases at the David Geffen School of Medicine at UCLA. She serves as Chair of the AIDS Clinical Trials Network, a global group of investigators focused on improving treatment for HIV and related co-infections. She received her medical degree from Geisel School of Medicine at Dartmouth and completed training in Infectious Diseases and Epidemiology and has been in practice 32 years. She specializes in HIV medicine and is the Co-Director of the UCLA Center for Clinical AIDS Research and Education.
Education & Training
Beth Israel Deaconess Medical CenterFellowship, Infectious Disease, 1988 - 1991- Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1985 - 1988
Geisel School of Medicine at DartmouthClass of 1985
Certifications & Licensure
CA State Medical License 1993 - 2028
GA State Medical License Active through 2013
American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
- Top Doctors:LA Area Castle Connolly, 2013
Clinical Trials
- A Study to Evaluate the Effect of Nandrolone Decanoate in Women With HIV-Associated Weight Loss
- Study of How Indinavir (an Anti-HIV Drug) and Rifabutin (a Drug Used to Treat MAC, an HIV-Associated Disease) Interact in HIV-Positive and HIV-Negative Adults
- Long-Term Assessment for Metabolic, Cardiovascular and Neurologic Problems in HIV-Infected Patients With Increased CD4 Cells Counts Following Anti-HIV Therapy
Publications & Presentations
PubMed
- Tecovirimat treatment of clade II mpox: a virological analysis of a randomised, double-blind, phase 3 trial.Dariia Vyshenska, Jonathan C Reed, Pavitra Roychoudhury, Lu Zheng, Maxine Olefsky
The Lancet. Microbe. 2026-07-29 - Inflammatory, Cardiac, and Lipid-Related Biomarkers in Relation to Residual MACE Risk in the REPRIEVE Trial.Steven K Grinspoon, Christopher DeFilippi, Triin Umbleja, Sara McCallum, Robert H Christenson
JACC. Advances. 2026-07-10 - Effect of inhaled interferon-β1a on SARS-CoV-2 diversity and evolution.Gregory E Edelstein, Tatum N Sass, Rinki Deo, Owen T Glover, Julie Boucau
Microbiology Spectrum. 2026-07-07
Journal Articles
- Safety and Impact of Low-Dose Methotrexate on Endothelial Function and Inflammation in Individuals with Treated Human Immunodeficiency Virus: AIDS Clinical Trials Grou...Steven G Deeks, James H Stein, Carl Fichtenbaum, Judith S Currier, Priscilla Y Hsue, Eric S Daar, Ahmed Tawakol, Michael Lederman, Tanvir Bell, Clinical Infectious Diseases
- Antiretroviral Concentrations in Hair Strongly Predict Virologic Response in a Large HIV Treatment-Naive Clinical TrialRaphael J Landovitz, Judith S Currier, Clinical Infectious Diseases
- Lower Pretreatment Gut Integrity Is Independently Associated with Fat Gain on Antiretroviral TherapyJudith S Currier, Peter W Hunt, Clinical Infectious Diseases
Other
- Mycobacterium avium complex (MAC) infections in HIV-infected patientsCurrier JS
http://www.uptodate.com/contents/mycobacterium-avium-complex-mac-infections-in-hiv-infected-patients
UpToDate, Wolters Kluwer Health - 2012-09-28 - Overview of nontuberculous mycobacteria (excluding MAC) in HIV-infected patientsCurrier JS, Leibowitz MR
http://www.uptodate.com/contents/overview-of-nontuberculous-mycobacteria-excluding-mac-in-hiv-infect
UpToDate, Wolters Kluwer Health - 2013-02-18 - Epidemiology of cardiovascular disease and risk factors in HIV-infected patientsCurrier JS
http://www.uptodate.com/contents/epidemiology-of-cardiovascular-disease-and-risk-factors-in-hiv-infe
UpToDate, Wolters Kluwer Health - 2013-02-07
Press Mentions
People Living with HIV Face Higher Odds for Heart FailureDecember 4th, 2025- ‘Kissing Bug’ Disease Reaches 32 US States, CDC Issues Warning: What to KnowSeptember 8th, 2025
- Deadly ‘Kissing Bug’ Disease Chagas Has Spread in the U.S. — Here’s Which States Are AffectedSeptember 6th, 2025
Grant Support
- Advancing Clinical Therapeutics Globally for HIV/AIDS and Other InfectionsUNIVERSITY OF CALIFORNIA LOS ANGELES2024–2027
- Advancing Clinical Therapeutics Globally for HIV/AIDS and Other InfectionsUNIVERSITY OF CALIFORNIA LOS ANGELES2024–2027
- UCLA-CDU CFARUNIVERSITY OF CALIFORNIA LOS ANGELES2022–2027
- UCLA AIDS Prevention and Treatment Clinical Trials UnitUNIVERSITY OF CALIFORNIA LOS ANGELES2007–2027
- Optimizing Antiretroviral Therapy In HIVNational Institute Of Allergy And Infectious Diseases2009–2012
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
